Current Hematologic Malignancy Reports

Papers
(The H4-Index of Current Hematologic Malignancy Reports is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Monoclonal Gammopathy-Associated Neuropathy119
Financial Toxicity in Patients with Hematologic Malignancies: a Review and Need for Interventions30
Sporadic and Familial Acute Myeloid Leukemia with CEBPA Mutations24
Telomere Biology Disorder: A Focus on Gastrointestinal and Hepatic Manifestations20
Mutant Calreticulin in MPN: Mechanistic Insights and Therapeutic Implications19
Management of Chronic Myeloid Leukemia in Children and Young Adults18
Correction to: Treatment of Myelodysplastic Syndromes for Older Patients: Current State of Science, Challenges, and Opportunities17
Contemporary Updates in the Prevention and Treatment of Graft-Versus-Host Disease17
Value in Myeloma Care: Myth or Reality16
Splicing Factor Mutations in Chronic Myelomonocytic Leukemia: Biological Consequences and Therapeutic Implications15
Clonal Hematopoiesis in Myeloproliferative Neoplasms Confers a Predisposition to both Thrombosis and Cancer15
Transplantation and Cellular Therapy for Older Adults—The MSK Approach14
Targeting Apoptosis in ALL14
Allogeneic Transplant for CMML13
0.2695300579071